Burnham is a partner of the San Diego Consortium for Regenerative Medicine.

Burnham is a partner of the San Diego Consortium for Regenerative Medicine.

Posted at 4:13 pm on January 28th, 2015

Burnham is a partner of the San Diego Consortium for Regenerative Medicine , by the by the UC San Diego, The Scripps Research Institute, the Salk Institute for Biological Studies and Burnham as a non-profit company to expand San Diego collaborative work in stem cell research.

The statewide ballot measure, a nonprofit provided in funding for stem cell research at California universities and research institutions California voters California voters, and called for the establishment of a company to grants and grants and. Loans for stem cell research, research facilities and other vital research opportunities.. * Robert Oshima, Professor and Program Director – trophoblast differentiation of human ES cells* Hudson Freeze, professor and program director – the role of glycans in human embryonic stem cells conversion to neural progenitor cells* Zhuohua Zhang, Assistant Professor – Modeling Parkinson’s disease using human embryonic stem* Ziwei Huang, Professor – New Chemokine – Derived Therapeutics targeting stem Cell migration* Vincent Chen, Assistant Professor – development of Neuro-Coupled human Embryonic Stem Cells Cell – Derived pacemaker cells* Alexey Terskikh, Assistant Professor – analysis of Candidate Neural crest cells from human embryonic stem cells* Gregg Duester, Professor – retinoic Acid – FGF antagonism during motor neuron differentiation human ES cells###CIRM was established in 2004 with the passage of Proposition 71, the California Stem Cell Research and cures initiative.Taxotere is a major growth driver to Aventis and is the basis the enterprise oncology franchise. Taxotere specifies for the treatment of metastatic breast and non-small cell and is examined and is being studied extensively in clinical trials for safety and effectiveness in Head Neck, early-stage breast cancer and gastric cancer. An additional Taxotere submissions to regulatory authorities for stomach cancer during the second half for the second half of year. In 2003, Taxotere generated world revenues of more than? 3 billion euro.

About Prostate. Prostate the third the world in the of cancer incidence and sixth of cancer mortality in men in the U.S. Are more than 230,000 American males to be diagnosed with prostate cancer this year and over 29,900 die of the disease.

Random Articles

Other Articles From Category "medicine":